[go: up one dir, main page]

FI875157A0 - Imidazopyridinfoereningar och foerfarande foer deras framstaellning. - Google Patents

Imidazopyridinfoereningar och foerfarande foer deras framstaellning.

Info

Publication number
FI875157A0
FI875157A0 FI875157A FI875157A FI875157A0 FI 875157 A0 FI875157 A0 FI 875157A0 FI 875157 A FI875157 A FI 875157A FI 875157 A FI875157 A FI 875157A FI 875157 A0 FI875157 A0 FI 875157A0
Authority
FI
Finland
Prior art keywords
imidazopyridinfoereningar
foerfarande foer
och foerfarande
deras framstaellning
foer deras
Prior art date
Application number
FI875157A
Other languages
English (en)
Other versions
FI875157A7 (fi
Inventor
Youichi Shiokawa
Masanobu Nagano
Hiromichi Itani
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628262A external-priority patent/GB8628262D0/en
Priority claimed from GB878723439A external-priority patent/GB8723439D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI875157A0 publication Critical patent/FI875157A0/fi
Publication of FI875157A7 publication Critical patent/FI875157A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI875157A 1986-11-26 1987-11-23 Imidazopyridinfoereningar och foerfarande foer deras framstaellning. FI875157A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628262A GB8628262D0 (en) 1986-11-26 1986-11-26 Imidazopyridine compounds
GB878723439A GB8723439D0 (en) 1987-10-06 1987-10-06 Imidazopyridine compounds

Publications (2)

Publication Number Publication Date
FI875157A0 true FI875157A0 (fi) 1987-11-23
FI875157A7 FI875157A7 (fi) 1988-05-27

Family

ID=26291587

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875157A FI875157A7 (fi) 1986-11-26 1987-11-23 Imidazopyridinfoereningar och foerfarande foer deras framstaellning.

Country Status (13)

Country Link
US (1) US4831041A (fi)
EP (1) EP0268989B1 (fi)
KR (1) KR880006237A (fi)
CN (1) CN87108027A (fi)
AU (1) AU8169387A (fi)
DE (1) DE3780263T2 (fi)
DK (1) DK608887A (fi)
ES (1) ES2064310T3 (fi)
FI (1) FI875157A7 (fi)
GR (1) GR3005685T3 (fi)
HU (1) HUT45526A (fi)
IL (1) IL84522A0 (fi)
NO (1) NO874904L (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
US5112834A (en) * 1987-07-16 1992-05-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazole protectorant for the stomach and intestine
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
ES2069137T3 (es) * 1990-07-30 1995-05-01 Takeda Chemical Industries Ltd Derivados de imidazopiridina y su uso.
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
GB9201693D0 (en) * 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
CN1046726C (zh) * 1994-07-28 1999-11-24 比克·古尔顿·劳姆贝尔格化学公司 咪唑并吡啶-吡咯烷酮、其制法和药用
EP0772614A1 (de) * 1994-07-28 1997-05-14 Byk Gulden Lomberg Chemische Fabrik GmbH Halogenimidazopyridine
EP0773944A1 (de) * 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Benzylimidazopyridine
CA2244770A1 (en) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh 3-methylimidazopyridines
WO1997027193A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenimidazopyridine
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
PT3141542T (pt) 2011-12-28 2020-06-16 Global Blood Therapeutics Inc Compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
AU2014237340C1 (en) 2013-03-15 2018-11-08 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AU2014237330A1 (en) 2013-03-15 2015-09-17 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
ES2890077T3 (es) 2013-03-15 2022-01-17 Global Blood Therapeutics Inc Compuestos y usos de los mismos para la modulación de la hemoglobina
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
PL3102208T5 (pl) 2014-02-07 2024-10-14 Global Blood Therapeutics, Inc. Krystaliczny polimorf wolnej zasady 2-hydroksy-6-((2-(1-izopropylo-1h-pirazol-5-ilo)pirydyn-3-ylo)metoksy)benzaldehydu
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
PL3383392T3 (pl) 2015-12-04 2025-11-17 Global Blood Therapeutics, Inc. Schematy dawkowania dla 2-hydroksy-6-((2-(1-izopropylo-1H-pirazol-5-ilo)pirydyn3-ylo)metoksy)benzaldehydu
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
ES2966707T3 (es) 2018-10-01 2024-04-23 Global Blood Therapeutics Inc Moduladores de la hemoglobina para el tratamiento de la drepanocitosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
DK608887A (da) 1988-05-27
AU8169387A (en) 1988-06-02
IL84522A0 (en) 1988-04-29
DK608887D0 (da) 1987-11-19
NO874904L (no) 1988-05-27
GR3005685T3 (fi) 1993-06-07
HUT45526A (en) 1988-07-28
NO874904D0 (no) 1987-11-25
EP0268989B1 (en) 1992-07-08
FI875157A7 (fi) 1988-05-27
KR880006237A (ko) 1988-07-22
DE3780263T2 (de) 1992-12-24
CN87108027A (zh) 1988-06-08
US4831041A (en) 1989-05-16
EP0268989A1 (en) 1988-06-01
DE3780263D1 (de) 1992-08-13
ES2064310T3 (es) 1995-02-01

Similar Documents

Publication Publication Date Title
FI870255A0 (fi) Olja och vatten avstoetande kopolymerer.
FI870233A0 (fi) Vakumisolerad skeppcontainer och foerfarande.
FI875157A0 (fi) Imidazopyridinfoereningar och foerfarande foer deras framstaellning.
FI861374A7 (fi) Foerfarande och anordning foer vaexelriktningstvinning.
FI865351L (fi) Luftfoerdelningssystem och luftfoerdelningsanlaeggning.
FI863331L (fi) Modifierade fiberprodukter och foerfarande foer deras framstaellning.
FI870246A7 (fi) Antiischemiska och antihypertensiva dihydropyridinfoereningar.
FI863330L (fi) Modifierade viskosfibrer och foerfarande foer deras framstaellning.
FI862161A0 (fi) Dragkrok och skyddsanordning foer dragkroket.
FI862675A7 (fi) Anordning foer provbelastning och kvalitetskontroll.
FI862704A0 (fi) Arrangemang foer matbestick och matlagningsredskap.
FI863939L (fi) Matarroer foer stycketorvs-/granuleringsmaskin och foerfarande foer framstaellning daerav.
FI861988A0 (fi) Skivcylinderlaos och nyckel.
FI862212A0 (fi) Anordning foer provbelastning och kvalitetkontroll.
FI862287A0 (fi) Fotopolymeriserbar blandning och fotoinitieringssystem.
FI862460A0 (fi) Mekanisk drivanordning foer pappersmaskiner och efterbehandlingsanordningar foer papper.
FI861914A0 (fi) Svetsningsfoerfarande och laongartat svetsningselement.
FI861430A0 (fi) Foerfarande och anlaeggning foer energilagring.
FI861422A0 (fi) Skivcylinderlaos och nyckel.
FI861114A0 (fi) Svetsningsfoerfarande och laongartad svetsningselektrod.
FI860985A0 (fi) Kombinerad arbetsfoerstaendingandeblankett och foerpackningskuvert foer glasoegonlinser.
FI863380A0 (fi) Foerfarande och anordning foer temperaturreglering.
FI863748L (fi) Faestanordning foer lavoarer och liknande.
FI863888A0 (fi) Skivformig sandwichprodukt foer paermar och liknande.
FI862066A0 (fi) Icke-laosbart bromssystem och tryckavlaegsnare.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.